Moving Closer to Universal CMV (Cytomegalovirus) Newborn Screening
Course: #33997Level: Intermediate 1 Hour 224 Reviews
Congenital cytomegalovirus (CMV) infection is the most common congenital infection in newborns and is a leading cause of hearing loss in children. Most infants with congenital CMV are asymptomatic at birth, but at risk for developing hearing impairment. With improved diagnostic testing for congenital CMV and more widespread recognition of the importance of early identification of infants at risk for hearing loss, there is increasing interest to screen all newborn infants for congenital CMV. This presentation will review the epidemiology and outcome of congenital CMV and the testing modalities to screen newborn infants. In addition, the current movement towards more widespread targeted and universal screening for congenital CMV will be discussed.
View this Course on Demand
Click Register to watch the full course.
Course Preview
Watch the first six minutes of the course. Register for immediate access to the full course, which will also appear on your Pending Courses page.
Learning Outcomes
- After this course learners will be able to describe the clinical spectrum and outcomes of congenital cytomegalovirus infection.
- After this course learners will be able to describe the appropriate diagnostic test to screen and diagnose congenital CMV in the newborn infant.
- After this course learners will be able to explain how to evaluate infant with congenital CMV and understand treatment recommendations for congenital CMV infection.
- After this course learners will be able to describe the difference between targeted and universal newborn CMV screening.
Course created on December 11, 2019
Agenda
| 0-15 Minutes | Incidence, symptoms and clinical presentation of CMV; Review of the most common sequelae which are hearing loss, opthamologic and cognitive impairment. |
| 15-30 Minutes | Initiatives of legislative updates on CMV screening legislation comparing targeted and universal screening; Benefits and limitations of three CMV screening and diagnostic test using saliva, urine and DBS (dried blood spot); Comparison of viral loads and sensitivity and specificity of the screening methods |
| 30-50 Minutes | Target vs Universal screening identification and intervention; Predictors of hearing loss in cases of symptomatic and asymptomic congential CMV; Other treatment options available including Early Intervention enrollment and follow-up audiological testing; Treatment options with Ganciclovir or Valganciclovir based on the classification of CMV – symptomic vs asymptomic with or without symptoms |
| 50-60 Minutes | Elements for comprehensive evaluation and treatment for symptomatic and asymptomatic infants with CMV. Limitations of target CMV screening; Challenges of universal CMV screening and follow-up; Current research being done to monitor the impact of universal vs. target screening and the treatment options available. |
Reviews
224 ReviewsPresented By
Shannon Ross
MD
Associate Professor of Pediatrics and Microbiology
Dr. Shannon Ross is an Associate Professor of Pediatrics and Microbiology in the Division of Pediatric Infectious Diseases at the University of Alabama at Birmingham. Dr. Ross earned her medical degree from the University of Alabama School of Medicine. She completed her Pediatric residency and Pediatric Infectious Diseases fellowship at the University of Alabama at Birmingham. During her fellowship training Dr. Ross also earned an MSPH in Clinical Research at the University of Alabama School of Public Health. Dr. Ross is an active clinician and researcher, with her research focused on the natural history and pathogenesis of congenital cytomegalovirus infection, with special emphasis on translational research exploring virological and clinical markers of outcome in CMV-related hearing loss.
More
Sponsor Disclosure: This Course is presented by Otometrics North America, a division of Natus (formerly Audiology Systems) in partnership with AudiologyOnline.
Content Disclosure: This learning event does not focus exclusively on any specific product or service.
Course participation information
To ensure you are ready to participate, please complete our short Test Drive to prepare your computer to view the course.
NOTE: Full attendance for all courses is mandatory. Please view the entire course.
Passing an online exam and completing a course evaluation will be required to earn continuing education credit.
Live Webinars allow presenter and participant interaction. The exam and course evaluation for these courses must be completed within 7 days of the event.
On-demand courses include texts, video and audio recordings of live webinars, and multimedia formats. The exam and course evaluation for on-demand courses must be completed within 30 days of course registration.
To participate in the course, complete the exam and course evaluation, and earn continuing education credit, you must be a AudiologyOnline member. Participants must complete the entire course; partial credit is not allowed.
AudiologyOnline is committed to ensuring accessibility to the widest possible audience. We are continually improving the user experience for everyone. If you have questions, requests, or would like to report an accessibility-related issue, please email accessibility@continued.com. We will review your request and respond in a timely manner.
Visit our Contact us page or give us a call if you have questions.
International Association for Continuing Education and Training
continued, LLC, DBA AudiologyOnline, is accredited by the International Association for Continuing Education and Training (IACET). continued complies with the ANSI/IACET Standard, which is recognized internationally as a standard of excellence in instructional practices. As a result of this accreditation, continued is authorized to issue the IACET CEU. continued, LLC, is authorized by IACET to offer 0.10 CEUs for this program.